Direct oral anticoagulants; a review for the non-specialist
Thrombin inhibitors and direct factor Xa inhibitors represent a major breakthrough in the field of anticoagulation pharmacotherapy. These novel agents have replaced warfarin as the oral anticoagulant of choice in certain indications, as they possess equal or superior efficacy and better safety prof...
Enregistré dans:
Auteur principal: | Thilina Gunawardena |
---|---|
Format: | article |
Langue: | EN |
Publié: |
PAGEPress Publications
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/fe609b572aae45f58e3bad1e170569c7 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Perioperative interruption of direct oral anticoagulants and vitamin K antagonists in patients with atrial fibrillation: A comparative analysis
par: Joseph R. Shaw, et autres
Publié: (2020) -
Stroke prevention in the elderly atrial fibrillation patient with comorbid conditions: focus on non-vitamin K antagonist oral anticoagulants
par: Turagam MK, et autres
Publié: (2015) -
Evaluation of the Determination of Dabigatran, Rivaroxaban, and Apixaban in Lupus Anticoagulant-Positive Patients
par: Jana Úlehlová, et autres
Publié: (2021) -
Rivaroxaban in acute venous thromboembolism: UK prescribing experience
par: Victoria Speed, et autres
Publié: (2021) -
Nuevos anticoagulantes orales en la prevención del ataque cerebrovascular
par: Soto V,Álvaro, et autres
Publié: (2012)